JW Therapeutics, an independent, innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, recently announced the appointments of Dr. Shaun Paul Cordoba as Chief Scientific Officer and Raymond J. Hage, Jr. as Senior Vice President of Corporate Development.
January 9, 2022
· 3 min read